Experimental Evaluation of Magnetic Flux Leakage for Railway Non-Destructive Testing
e-Journal of Nondestructive Testing · 2026-07 · 31 (7)
DOI: 10.58286/33244 ↗Kurz gefasst
Fachartikel in der Zeitschrift e-Journal of Nondestructive Testing, 2026-07. Verfasst von Alessandro paolo Daga und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Continuous monitoring of railways is essential for enabling condition-based and predictive maintenance, yet current inspections rely on periodic diagnostic runs that offer limited temporal coverage. Magneto-inductive Non-Destructive Testing (NDT), and in particular Magnetic Flux Leakage (MFL), represents a promising solution for lightweight automated systems capable of operating alongside commercial traffic. This work investigates the feasibility of MFL sensing for automated rail monitoring using a compact two-wheel bogie that magnetizes the rail with permanent magnets and carries coil and Hall sensors positioned between the magnet poles. Field tests on a single rail containing artificial defects show that localized anomalies in both the rail head and web can be reliably detected under low-speed operating conditions. These results confirm the potential of compact magneto-inductive sensing as a practical basis for continuous, automated monitoring of railway infrastructure.
Zitieren
APA
Daga, A. P., Garibaldi, L., & Canova, A. (2026). Experimental Evaluation of Magnetic Flux Leakage for Railway Non-Destructive Testing. e-Journal of Nondestructive Testing, 31(7). https://doi.org/10.58286/33244
Vancouver
Daga AP, Garibaldi L, Canova A. Experimental Evaluation of Magnetic Flux Leakage for Railway Non-Destructive Testing. e-Journal of Nondestructive Testing. 2026;31(7). doi:10.58286/33244
BibTeX
@article{Daga2026,
author = {Daga, Alessandro paolo and Garibaldi, Luigi and Canova, Aldo},
title = {Experimental Evaluation of Magnetic Flux Leakage for Railway Non-Destructive Testing},
journal = {e-Journal of Nondestructive Testing},
year = {2026},
volume = {31},
number = {7},
doi = {10.58286/33244}
}
EUVIMED